Tenderwize
Retour à la recherche

Contrat de réduction pour les médicaments à base de Trientine

AOK Niedersachsen. Die Gesundheitskasse.·Hannover, Germany·Deadline May 27, 2028 · 553 days left·Open·Supplies·Framework
Titre original de l'avis

Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Trientin (ATC-Code: A16AX12).

58/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesFrameworkOpen
Pourquoi ce score ?

Opportunité

58 / 100

Complexité

63 / 100

Facteurs de risque

No value, volume, reimbursement economics or guaranteed demand is provided, preventing reliable pricing and profitabili...

AOK Niedersachsen may replace the open-house contracts with exclusive contracts during the period, causing automatic te...

No procurement documents available

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Informations clés

Pouvoir adjudicateur
AOK Niedersachsen. Die Gesundheitskasse.
Pays
Allemagne
CPV
33600000 - Pharmaceutical products
Date limite
May 27, 2028

Aperçu

Moderate opportunity

Faits clés

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Jul 2028
  • Supply or provision of medicinal products containing the active substance trientine (ATC A16AX12) under a non-exclusive reimbursement agreement.
  • Participation in AOK Niedersachsen's open-house model, with uniform contract terms, conditions and access procedures for all participants.
Afficher le résumé complet

Open-house framework-style arrangement for non-exclusive reimbursement contracts covering medicinal products containing trientine (ATC A16AX12) in Germany. AOK Niedersachsen intends to offer identical contract terms to all eligible pharmaceutical entrepreneurs without a competitive selection decision. Contracts may be concluded during the period, initially from 1 August 2026, and may end earlier if exclusive contracts enter into force. Contract documents and commercial conditions were not provided for analysis.

Risques

No value, volume, reimbursement economics or guaranteed demand is provided, preventing reliable pricing and profitabili...

AOK Niedersachsen may replace the open-house contracts with exclusive contracts during the period, causing automatic te...

No procurement documents available

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • The participant must be a pharmaceutical entrepreneur within the meaning of Section 4(18) AMG, or a contractual association of pharmaceutical entrepreneurs, in relation to the...
  • A medicinal product may be placed on the German market only by a pharmaceutical entrepreneur established in Germany, another EU Member State or another EEA contracting state...
  • A local representative may participate only if it is itself a pharmaceutical entrepreneur for the medicinal products concerned.

Acheteur

Localisation

Hannover, DEU

Identifiant

AOK- Niedersachsen. Die Gesundheitskasse

Activité

Health

Lots (1)

LOT-0000

Non-exclusive Trientine Reimbursement Agreement

Non-exclusive reimbursement contract under Section 130a(8) SGB V for medicinal products containing trientine (ATC A16AX12), operated through an open-house model. Contracts may be concluded by eligible pharmaceutical entrepreneurs during the maximum 24-month period, subject to uniform conditions and possible early replacement by exclusive contracts.

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE929, Germany

Durée

Jul 2026 - Jul 2028

Catégorie

Pharmaceutical products

Date limite

Deadline May 27, 2028

Détails de la procédure

Date de publication
11 Jun 2026
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
402714-2026

Appels d'offres similaires

Cookies & Privacy

With your consent, we use Google Analytics, Microsoft Clarity (session recordings) and Google Ads cookies to understand how Tenderwize is used and to measure our advertising. You can change your choice at any time via “Cookie Settings” in the footer. Cookie Policy · Privacy Policy